CCCC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

C4 Therapeutics Inc

NASDAQ | CCCC

2.61

USD

$0.00

(

0.00%

)

At Close (As of Dec 4, 2025)

$272.33M

Market Cap

-

P/E Ratio

-1.67

EPS

$5.10

52 Week High

$1.08

52 Week Low

HEALTHCARE

Sector

CCCC Chart

Recent Chart
Price Action

CCCC Technicals

Tags:

CCCC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $36M
Total Revenue $36M
Cost Of Revenue $7.9M
Costof Goods And Services Sold $7.9M
Operating Income -$120M
Selling General And Administrative $42M
Research And Development $111M
Operating Expenses $155M
Investment Income Net -
Net Interest Income $14M
Interest Income $14M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$105M
Income Tax Expense $131K
Interest And Debt Expense -
Net Income From Continuing Operations -$105M
Comprehensive Income Net Of Tax -
Ebit -$105M
Ebitda -$103M
Net Income -$105M

Revenue & Profitability

Earnings Performance

CCCC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $350M
Total Current Assets $258M
Cash And Cash Equivalents At Carrying Value $55M
Cash And Short Term Investments $55M
Inventory -
Current Net Receivables $3.1M
Total Non Current Assets $92M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $22M
Short Term Investments $189M
Other Current Assets $9.8M
Other Non Current Assets -
Total Liabilities $134M
Total Current Liabilities $45M
Current Accounts Payable $1.3M
Deferred Revenue -
Current Debt -
Short Term Debt $5.8M
Total Non Current Liabilities $88M
Capital Lease Obligations $66M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $66M
Other Current Liabilities $19M
Other Non Current Liabilities -
Total Shareholder Equity $216M
Treasury Stock -
Retained Earnings -$634M
Common Stock $7K
Common Stock Shares Outstanding $69M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$65M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.8M
Capital Expenditures $180K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$51M
Cashflow From Financing $45M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$194K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$105M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $36M
Total Revenue $36M
Cost Of Revenue $7.9M
Costof Goods And Services Sold $7.9M
Operating Income -$120M
Selling General And Administrative $42M
Research And Development $111M
Operating Expenses $155M
Investment Income Net -
Net Interest Income $14M
Interest Income $14M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$105M
Income Tax Expense $131K
Interest And Debt Expense -
Net Income From Continuing Operations -$105M
Comprehensive Income Net Of Tax -
Ebit -$105M
Ebitda -$103M
Net Income -$105M

CCCC News

CCCC Profile

C4 Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

C4 Therapeutics, Inc. is an innovative biopharmaceutical company based in Watertown, Massachusetts, focused on developing advanced therapeutic candidates that selectively target and degrade disease-causing proteins. Specializing in oncology and neurodegenerative diseases, the company's proprietary dynamic protein degradation platform utilizes state-of-the-art biological mechanisms to offer groundbreaking treatment solutions for patients with significant unmet medical needs. Positioned as a leader in the biopharmaceutical industry, C4 Therapeutics is dedicated to transforming patient care by redefining treatment paradigms and improving clinical outcomes through its pioneering approaches.

LPTX
+368.57%
$2.05
VHAI
-33.33%
$0.00
KALA
+17.84%
$1.09
PAVS
+1.17%
$0.03
RR
+18.53%
$4.22
TSLA
+4.07%
$446.74
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
KITT
-19.87%
$1.25
NVDA
+1.17%
$181.69
PFE
+1.67%
$25.57
TNFA
+38.16%
$4.67
QCLS
+38.16%
$4.67
ADAP
-15.14%
$0.05
ASST
-3.51%
$1.01
ONDS
+0.61%
$8.97
PMCB
+39.49%
$1.09
SOND
-23.45%
$0.12
IXHL
+9.97%
$0.49
RMBL
+60.50%
$3.21
INTC
-4.43%
$41.81
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
AMZN
-0.87%
$232.38
SRM
+53.27%
$10.30
PLUG
-0.98%
$2.20
BYND
+3.20%
$1.29
RGTI
+9.96%
$28.63
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
SNAP
+0.52%
$7.66
SOFI
-0.13%
$29.03
AFMD
-34.94%
$0.18
BMNU
+6.93%
$8.64
NIO
+3.13%
$4.94
BBD
+1.81%
$3.64
M
-1.10%
$22.46
IRBT
-12.09%
$2.98
NFLX
-1.61%
$102.28
QBTS
+9.74%
$27.52
CRCL
+11.42%
$86.29
APLD
+4.67%
$29.36
PFSA
-1.10%
$0.18
TWOH
0.00%
$0.00
BITF
+0.31%
$3.11
CCL
+0.77%
$26.04
BMNR
+4.46%
$35.16
ABEV
+1.55%
$2.62
GRYP
-10.38%
$1.38
ACHR
+3.13%
$8.61
MODV
-25.22%
$0.43
PLRZ
+117.06%
$15.39
ABLV
+33.76%
$0.96
PMI
+24.75%
$2.52
XOM
+2.09%
$117.80
KDLY
+11.70%
$0.54
STLA
+4.65%
$11.46
SMR
+9.18%
$21.99
AAL
-0.64%
$14.46
F
+0.07%
$13.10
RIVN
+0.14%
$17.55
INHD
-3.63%
$0.13
CLF
+1.00%
$13.03
BURU
+5.08%
$0.23
FI
+5.86%
$66.95
PLTR
+0.81%
$177.51
SAND
-6.04%
$12.12
KVUE
+0.02%
$16.97
SHOT
-74.37%
$0.39
IONZ
-7.20%
$4.16
BAC
+0.72%
$54.48
VALE
+1.24%
$13.46
ZAPP
-46.30%
$0.15
TEVA
+3.53%
$27.83
IREN
+3.11%
$45.33
IONQ
+11.24%
$54.12
BTBT
+1.28%
$2.36
MARA
0.00%
$12.47
GOOGL
-1.09%
$316.14
AAPL
-1.37%
$280.24
ITUB
+2.64%
$8.12
YGMZ
-15.21%
$0.06
PLTD
0.00%
$6.73
DNN
+2.79%
$2.77
CPNG
-0.56%
$26.56
WBD
-1.20%
$24.27
NVO
+0.74%
$47.92
VIVK
+8.75%
$0.10
META
-1.15%
$639.60
VSME
-29.06%
$0.11
CHR
-2.74%
$0.03
LAZR
+26.90%
$1.11
MU
-3.86%
$225.11
CRWV
+5.89%
$84.04
ASTS
+14.43%
$70.30
VSA
+0.53%
$0.09
SOUN
+5.60%
$12.44
T
-0.29%
$25.24
SONN
-59.35%
$1.26
DAL
+3.60%
$67.49
LPTX
+368.57%
$2.05
VHAI
-33.33%
$0.00
KALA
+17.84%
$1.09
PAVS
+1.17%
$0.03
RR
+18.53%
$4.22
TSLA
+4.07%
$446.74
IPG
-1.95%
$24.57
AXDX
-61.36%
$0.03
KITT
-19.87%
$1.25
NVDA
+1.17%
$181.69
PFE
+1.67%
$25.57
TNFA
+38.16%
$4.67
QCLS
+38.16%
$4.67
ADAP
-15.14%
$0.05
ASST
-3.51%
$1.01
ONDS
+0.61%
$8.97
PMCB
+39.49%
$1.09
SOND
-23.45%
$0.12
IXHL
+9.97%
$0.49
RMBL
+60.50%
$3.21
INTC
-4.43%
$41.81
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
AMZN
-0.87%
$232.38
SRM
+53.27%
$10.30
PLUG
-0.98%
$2.20
BYND
+3.20%
$1.29
RGTI
+9.96%
$28.63
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
SNAP
+0.52%
$7.66
SOFI
-0.13%
$29.03
AFMD
-34.94%
$0.18
BMNU
+6.93%
$8.64
NIO
+3.13%
$4.94
BBD
+1.81%
$3.64
M
-1.10%
$22.46
IRBT
-12.09%
$2.98
NFLX
-1.61%
$102.28
QBTS
+9.74%
$27.52
CRCL
+11.42%
$86.29
APLD
+4.67%
$29.36
PFSA
-1.10%
$0.18
TWOH
0.00%
$0.00
BITF
+0.31%
$3.11
CCL
+0.77%
$26.04
BMNR
+4.46%
$35.16
ABEV
+1.55%
$2.62
GRYP
-10.38%
$1.38
ACHR
+3.13%
$8.61
MODV
-25.22%
$0.43
PLRZ
+117.06%
$15.39
ABLV
+33.76%
$0.96
PMI
+24.75%
$2.52
XOM
+2.09%
$117.80
KDLY
+11.70%
$0.54
STLA
+4.65%
$11.46
SMR
+9.18%
$21.99
AAL
-0.64%
$14.46
F
+0.07%
$13.10
RIVN
+0.14%
$17.55
INHD
-3.63%
$0.13
CLF
+1.00%
$13.03
BURU
+5.08%
$0.23
FI
+5.86%
$66.95
PLTR
+0.81%
$177.51
SAND
-6.04%
$12.12
KVUE
+0.02%
$16.97
SHOT
-74.37%
$0.39
IONZ
-7.20%
$4.16
BAC
+0.72%
$54.48
VALE
+1.24%
$13.46
ZAPP
-46.30%
$0.15
TEVA
+3.53%
$27.83
IREN
+3.11%
$45.33
IONQ
+11.24%
$54.12
BTBT
+1.28%
$2.36
MARA
0.00%
$12.47
GOOGL
-1.09%
$316.14
AAPL
-1.37%
$280.24
ITUB
+2.64%
$8.12
YGMZ
-15.21%
$0.06
PLTD
0.00%
$6.73
DNN
+2.79%
$2.77
CPNG
-0.56%
$26.56
WBD
-1.20%
$24.27
NVO
+0.74%
$47.92
VIVK
+8.75%
$0.10
META
-1.15%
$639.60
VSME
-29.06%
$0.11
CHR
-2.74%
$0.03
LAZR
+26.90%
$1.11
MU
-3.86%
$225.11
CRWV
+5.89%
$84.04
ASTS
+14.43%
$70.30
VSA
+0.53%
$0.09
SOUN
+5.60%
$12.44
T
-0.29%
$25.24
SONN
-59.35%
$1.26
DAL
+3.60%
$67.49
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.